BBNX

Beta Bionics, Inc. · Healthcare · Market cap $827.8M

Insiders sold $3.0M net in the last 90 days ·6 sellers, 0 buyers· 7 of 12 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 5, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$5.2M

reported sales (SEC code S)

Unique Insiders

8

in the rolling window

Latest filing

Oct 5, 2026

Hopman Mark

Beta Bionics, Inc. (BBNX) has 54 SEC Form 4 filings (75 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Oct 5, 2026.

Inside the rolling window, 8 insiders at Beta Bionics, Inc. reported no open-market purchases and 45 open-market sales totaling $5.2M. The most active filer is Chief Commercial Officer Hopman Mark with 12 filings. Insiders have net sold $3.8M over the trailing 6 months. The most recent open-market filing is a sale of 370 shares by Chief Commercial Officer Hopman Mark, dated Oct 1, 2026, worth $7K.

  • Industry:Medical - Devices
  • CEO:Sean T. Saint
  • Employees:422
  • HQ:Irvine, CA, US
  • IPO:2025-01-30
Source
Sale$7KOct 5SEC ↗
Jones ChristyFirst in 3 months
Sale$148KSep 23SEC ↗
Sale$1.3MSep 18SEC ↗
Sale$58KSep 17SEC ↗
Sale$620KSep 17SEC ↗
Sale$12KSep 15SEC ↗
Sale$113KSep 4SEC ↗
Sale$102KSep 3SEC ↗
Mensinger MikeFirst in 3 months
Sale$84KSep 3SEC ↗
Russell Steven JonFirst in 3 months
Sale$81KSep 3SEC ↗
Saint SeanFirst in 3 months
Sale$322KSep 3SEC ↗
Sale$128KSep 3SEC ↗
Sale$87KJul 2SEC ↗
Sale$83KJul 2SEC ↗
Sale$21KJun 25SEC ↗
Sale$19KJun 25SEC ↗
Sale$3KJun 5SEC ↗
Sale$39KJun 5SEC ↗
Mensinger MikeFirst in 3 months
Sale$55KJun 3SEC ↗
Sale$67KJun 3SEC ↗
Saint SeanFirst in 3 months
Sale$213KJun 3SEC ↗
Sale$53KJun 3SEC ↗
Feider StephenFirst in 3 months
Sale$84KJun 3SEC ↗
Jones ChristyFirst filing
Sale$20KMay 26SEC ↗
Lezack AdamFirst in 6 months
Sale$10KMay 26SEC ↗
Showing 1–25 of 45
1 / 2

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does BBNX have?

Beta Bionics, Inc. (BBNX) has 54 SEC Form 4 filings (75 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Oct 5, 2026.

When was the most recent SEC Form 4 filing for BBNX?

The most recent Form 4 filing for BBNX on Tracefour is dated Oct 5, 2026.

Who is the most active insider at BBNX?

The most active SEC Form 4 filer at BBNX in the rolling window is Chief Commercial Officer Hopman Mark, with 12 filings.

What is the net insider flow at BBNX over the last 6 months?

Over the trailing 180 days, insiders at BBNX have net sold $3.8M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at BBNX in the current window?

Inside the rolling window, insiders at BBNX bought $0 and sold $5.2M based on SEC Form 4 filings.

Can I get alerts for BBNX insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Beta Bionics, Inc. (BBNX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Beta Bionics, Inc. is in the Healthcare sector.